Navigation Sciences

Real-Time Margin Measurement for Precision Cancer Surgery

Sign-up for Updates

Home

Real-Time Margin Measurement for Precision Cancer Surgery

Real-Time In Vivo Measurement

for Precision Cancer Surgery

Meet Navigation Sciences at the MedTech Conference

October 18–21, 2026

Boston Convention & Exhibition Center

Addressing Unmet Needs in Soft Tissue Surgery

Navigation Sciences is developing the NaviSci™ system to address the growing need to locate and remove soft tissue cancers.

Real-time GPS Navigation

Real-time GPS
Navigation

Minimally Invasive

Precise
Control

icon-minimally-invasive

Minimally
Invasive

The NaviSci System, which has completed a clinical feasibility trial, has great potential to:

  • Conserve function
  • Improve surgical workflow

There are approximately 450,000 soft tissue cancer diagnoses annually in the U.S. where NaviSci has potential application.

NaviSci’s IDE clinical feasibility study was conducted in early stage lung cancer, where there are more than 76,000 new cases each year in the U.S.; the number is growing annually due to increasing adoption of CT x-ray screening.

Recent News

Publications

Recent News

Publications

Learn more…

Navigation Sciences Executive Summary

Navigation Sciences
Executive Summary

Navigation Sciences Corporate PPT

Navigation Sciences
Corporate PPT

Entering the Era of “Precision Cancer Surgery“

Entering the Era of
“Precision Cancer Surgery“

LSI Emerging MedTech Summit Video

LSI Emerging MedTech
Summit Video

NaviSci is based on technology developed by the company’s co-founders, leaders in thoracic surgery and advanced surgical navigation technology, Raphael Bueno, M.D., Chief, Thoracic Surgery, and Jayender Jagadeesan, Ph.D., Associate Professor of Radiology, both at Brigham & Women’s Hospital and Harvard Medical School. View our leadership team

Info@navigationsci.com
Brookline, MA